Research & Publications
 |
| : |
| The promise of bio-pharmaceuticals is a healthier world, but the rising cost of prescription drugs is encouraging governments to increase their involvement in the development and delivery of medicines. The consequence is often punitive action against companies that are creating the wonder drugs of the 21st century—and delays in getting medicine to those who need it most. |  Brett J. SkinnerDirector, Health Policy Research (416) 363-6575 ext.224 |